Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world add-on lacosamide study in focal-onset epilepsy
ChiCTR2100042485Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lacosamide in epilepsy and Focal Onset Epilepsy (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Change in seizure frequency per 4 weeks from retrospective baseline to maintenance and 50% responder rate. Started Dec 2020; status: recruiting.
02
Drugs
lacosamide
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on ChiCTR2100042485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042485.